Bruker Acquires DISQVER Metagenomic Sequencing Platform From Noscendo
July 17, 2026
Bruker acquired the DISQVER clinical metagenomics sequencing platform from Noscendo GmbH to expand its infection diagnostics portfolio. DISQVER enables whole-genome sequencing-based pathogen detection directly from blood samples and remains available for research use only while Bruker advances regulatory registration for diagnostic applications.
- Buyers
- Bruker
- Targets
- DISQVER clinical metagenomics sequencing platform (DISQVER)
- Sellers
- Noscendo GmbH
- Industry
- Healthcare Services
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
SeqOne Acquires Congenica
September 2, 2025
Software
SeqOne has acquired Congenica, a UK clinical genomics software company spun out of the Wellcome Sanger Institute, creating one of the largest pure‑play genomics software firms serving over 160 laboratories in 30+ countries. The combined business will integrate SeqOne's AI-driven NGS analysis platform with Congenica's clinical decision‑support tools to accelerate rare disease diagnoses and personalized cancer therapies while expanding SeqOne's UK presence.
-
Bruker Corporation Acquires biocrates life sciences ag
June 3, 2025
Biotechnology
Bruker Corporation has acquired biocrates life sciences ag, an Innsbruck, Austria-based leader in mass-spectrometry-based quantitative metabolomics. The deal adds biocrates' metabolomics kits, assays, software and contract research services to Bruker's multiomics strategy, expanding Bruker's MS-based metabolomics and integrated multiomics capabilities. Financial terms were not disclosed.
-
QIAGEN Acquires Verogen
January 9, 2023
Biotechnology
QIAGEN completed the acquisition of Verogen for $150 million in cash, bringing Verogen’s NGS-based human identification and forensic genomics products and the GEDmatch database into QIAGEN’s forensics portfolio. The deal gives QIAGEN exclusive distribution rights for the MiSeq FGx forensic sequencer version and is intended to expand QIAGEN’s capabilities and commercial footprint in the fast-growing Human ID/forensics market.
-
Eurobio Scientific Acquires GenDx (Genome Diagnostics B.V.)
October 4, 2022
Biotechnology
Paris-based Eurobio Scientific has acquired all outstanding shares of Dutch transplant diagnostics specialist GenDx (Genome Diagnostics B.V.), following a share purchase agreement signed on August 17. The acquisition expands Eurobio's molecular diagnostics portfolio in transplantation and secures the company legacy with proceeds funding a GenDx foundation established by the founders.
-
Biocompare (CompareNetworks) Acquires SEQanswers
April 27, 2022
Healthcare Services
Biocompare, a division of CompareNetworks, acquired SEQanswers, an online community and forum for Next Generation Sequencing (NGS) users. The acquisition adds a dedicated NGS community and content hub to Biocompare's life-science product information and media portfolio to better serve researchers and NGS practitioners.
-
Bionano Genomics Acquires BioDiscovery
October 12, 2021
Software
Bionano Genomics agreed to acquire BioDiscovery, a provider of NxClinical genomics analysis software, in a deal worth up to $100 million in cash and equity. The acquisition will integrate BioDiscovery's platform-agnostic analysis and reporting tools with Bionano's optical genome mapping technology to accelerate variant analysis and broaden Bionano's market reach; BioDiscovery founder Soheil Shams will join Bionano as Chief Informatics Officer.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.